Recent headlines about the widespread use of prescription drugs for weight loss have made it a prominent and relevant topic in discussions about health and well-being. In this episode, Bill Coyle, ZS’s global head of biopharma, and Mandi White-Ajmani, Ph.D., clinical psychologist and owner of Small Brooklyn Psychology, talk about the underlying challenges obesity presents to society and healthcare, even as new treatments emerge.
Highlights from the episode:
- Dr. White-Ajmani shares her personal weight loss journey and how it has affected her life
- The importance of reducing stigma and promoting open conversations about obesity
- The role of biopharma companies in developing innovative solutions and providing support and resources for people on their weight loss journeys
Read more about how healthcare and biopharma can tackle obesity:
Obesity is a public health crisis: Pharma needs a commercial model that can solve it
GLP-1s give us a path to beating obesity, but making it a reality won’t be easy
To conquer the obesity market, healthcare must treat it like a chronic illness
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
